BLINDNESS AFTER SNAKE-BITE

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Blindness after snake-bite.

REPORTS of blindness produced by snake-bite are extremely rare. In one case described recently by Davenport and Budden (1953) bilateral secondary optic atrophy developed; the patient received Antivenine serum on the day of the bite and the changes in the eyes first appeared 6 days later. Jaksch (1897) mentions cases in which snake-bite led to amaurosis, but gives no detailed descriptions or oph...

متن کامل

Use of neostigmine after snake bite.

Cobra venom consists of a neurotoxin which is responsible for respiratory paralysis simulating that associated with a non-depolarizing muscle relaxant. A combination of artificial respiration and neostigmine has been useful in resuscitating a child bitten by a snake.

متن کامل

Snake bite.

Snake bite is a common and frequently devastating environmental and occupational disease, especially in rural areas of tropical developing countries. Its public health importance has been largely ignored by medical science. Snake venoms are rich in protein and peptide toxins that have specificity for a wide range of tissue receptors, making them clinically challenging and scientifically fascina...

متن کامل

The Global Snake Bite Initiative: an antidote for snake bite.

Clinicians have for a long time witnessed the tragedy of injury, disability, and death from snake bite that is a daily occurrence in many parts of Africa, Asia, and Latin America. To many people living in these regions, including some of the world’s poorest communities, snake bite is an ever present occupational risk and environmental hazard, an additional penalty of poverty. Like malaria, deng...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: British Journal of Ophthalmology

سال: 1956

ISSN: 0007-1161

DOI: 10.1136/bjo.40.1.57